Openbookopenbook
Equity
KIDS
+0.0 · +0.00%
USD · NASDAQ

Orthopediatrics Corp(KIDS) Stock Analysis | Healthcare

USD --+0.00%
Reward63Moderate
Risk59Medium-High
75%Data
Thin -16% profit margin · Revenue growing 15% YoY
Profitless Growth
Market Cap:669.72M
ⓘ
Reward Rating
63
Moderate
Reward Assessment
75% data coverage
Top 50% of stocksView factors
ⓘ
Risk Rating
59
Medium-High
Risk Assessment
6 metrics flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on KIDS to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for KIDS, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $27.22.

What is Orthopediatrics Corp?

, a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.

KIDS · Verdict

Solid reward · elevated risk

KIDS's standout is growth; cash flow and balance sheet weigh on the picture.

Based on 88% data coverage

KIDS · Verdict

What’s working & what to watch

Strengths 1

  • Growth96/100

    Revenue +24.6% CAGR

Watchouts 4

  • Cash flow29/100

    -7% free-cash-flow margin

  • Balance sheet30/100

    Current ratio 5.55

  • Profitability32/100

    -17% net margin · -11% ROE

  • Valuation37/100

    Below average

Model-based scoring. For information only — not financial advice.

What is Orthopediatrics Corp?

, a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 669.72M.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Moderate volatility with meaningful macro and earnings sensitivity.
Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (63)

The scoring profile indicates moderate reward potential, with growth and momentum as the leading contributors. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.

REVXFSmall Cap / 701M market cap
Revenio Group Oyj
Compare
CTKBSmall Cap / 625M market cap
Cytek Biosciences Inc
Compare
XVIPFSmall Cap / 608M market cap
Xvivo Perfusion AB (publ)
Compare
Company Information
SectorHealthcare
IndustryMedical Devices
Market Cap669.72M
P/E RatioN/A
Dividend YieldN/A
Beta0.965
Insider Activity
12M windowBearish
Shares soldShares bought
0-3months
0
0
3-6months
558,171 shares
$1.0M
0
6-9months
0
0
9-12months
0
0
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.